ORION PHARMACEUTICAL RESEARCH EARMARKED FOR EIB MONEY
June 1st, 2009
BY KEITH NUTHALL
THE EUROPEAN Investment Bank (EIB) is planning to lend Finland's Orion Oyj Euro 75 million to help it stage pharmaceutical research and development work from this year to 2012. Part of a Euro 300 million programme, the work would be carried out within Orion's existing R&D facilities, laboratories, pilot plants and clinical centres.
ENDS
THE EUROPEAN Investment Bank (EIB) is planning to lend Finland's Orion Oyj Euro 75 million to help it stage pharmaceutical research and development work from this year to 2012. Part of a Euro 300 million programme, the work would be carried out within Orion's existing R&D facilities, laboratories, pilot plants and clinical centres.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.